Holder of Procter & Gamble (NYSE: PG) to sell $27.3M in stock

Rhea-AI Filing Summary

The Procter & Gamble Company has a shareholder filing a notice of proposed sale of 173,268 shares of common stock, with an aggregate market value of $27,315,700.20. The planned sale is tied to the exercise and sale of a stock option on 02/11/2026.

The shares are to be sold for cash through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The filing notes total common shares outstanding of 2,324,000,685 and includes a representation that the seller is not aware of undisclosed material adverse information about Procter & Gamble.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	173268	27315700.20	2324000685	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/11/2026	Exercise and Sale of Stock Option	The Procter & Gamble Company			173268	02/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Procter & Gamble (PG) disclose in this Form 144 filing?

The filing shows a shareholder intends to sell 173,268 Procter & Gamble common shares on 02/11/2026 for an aggregate market value of $27,315,700.20, following an exercise and sale of a stock option paid in cash.

How many Procter & Gamble (PG) shares are planned to be sold and at what value?

The planned transaction covers 173,268 shares of Procter & Gamble common stock with an aggregate market value of $27,315,700.20. These figures come from the Form 144 securities information table detailing the number of shares and their total market value.

How are the Procter & Gamble (PG) shares being acquired for this Form 144 sale?

The shares are being acquired through an exercise and sale of a stock option dated 02/11/2026. The filing states 173,268 common shares are acquired from The Procter & Gamble Company with the nature of payment listed as cash on that same date.

Through which broker and market will the Procter & Gamble (PG) shares be sold?

The Form 144 indicates the shares will be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York. The New York Stock Exchange (NYSE) is named as the securities exchange for this planned sale of Procter & Gamble common stock.

How many Procter & Gamble (PG) common shares are outstanding in this Form 144?

The filing reports 2,324,000,685 shares of Procter & Gamble common stock outstanding. This figure appears in the securities information table alongside the 173,268 shares proposed for sale, providing context for the size of the planned transaction relative to total shares.

What representation does the seller make in this Procter & Gamble (PG) Form 144?

The seller represents that they do not know any material adverse information about Procter & Gamble’s current or prospective operations that has not been publicly disclosed. The notice also references possible use of a written trading plan under Rule 10b5-1.